As of 30 Sep 2025, 250 institutional investors reported holding 3,031,905 shares of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 261,391 | $54,054,438 | +$17,783,271 | $206.52 | 46 |
| 2025 Q3 | 3,031,905 | $544,022,410 | -$12,934,226 | $179.29 | 250 |
| 2025 Q2 | 3,155,408 | $509,245,856 | -$41,077,763 | $161.33 | 247 |
| 2025 Q1 | 3,418,328 | $576,824,224 | +$1,866,805 | $170.12 | 266 |
| 2024 Q4 | 3,418,857 | $568,580,158 | +$41,645,148 | $166.21 | 253 |
| 2024 Q3 | 3,143,605 | $540,228,542 | -$50,274,497 | $171.93 | 252 |
| 2024 Q2 | 3,468,418 | $534,289,452 | +$6,575,921 | $153.99 | 247 |
| 2024 Q1 | 3,399,038 | $522,621,545 | -$94,532,990 | $153.77 | 240 |
| 2023 Q4 | 4,017,594 | $634,837,157 | -$30,986,867 | $158.06 | 254 |
| 2023 Q3 | 4,190,296 | $613,262,596 | -$62,820,801 | $146.35 | 239 |
| 2023 Q2 | 4,617,487 | $707,129,055 | -$19,966,454 | $153.14 | 247 |
| 2023 Q1 | 4,700,385 | $728,635,260 | -$18,428,171 | $155.03 | 241 |
| 2022 Q4 | 4,877,768 | $751,529,554 | +$55,433,739 | $154.13 | 239 |
| 2022 Q3 | 4,496,690 | $593,813,874 | +$22,209,350 | $131.98 | 212 |
| 2022 Q2 | 4,332,609 | $587,753,929 | -$18,206,139 | $135.56 | 218 |
| 2022 Q1 | 4,448,675 | $663,407,924 | -$82,106,064 | $149.14 | 212 |
| 2021 Q4 | 4,955,742 | $802,113,791 | -$46,741,875 | $161.96 | 239 |
| 2021 Q3 | 5,178,909 | $859,978,174 | -$14,178,042 | $166.06 | 230 |
| 2021 Q2 | 5,220,166 | $900,985,426 | -$80,585,265 | $172.62 | 227 |
| 2021 Q1 | 5,725,862 | $919,195,735 | -$21,822,779 | $160.50 | 232 |
| 2020 Q4 | 5,809,688 | $976,622,166 | -$78,183,499 | $167.99 | 232 |
| 2020 Q3 | 6,096,208 | $959,021,765 | -$32,144,151 | $157.26 | 210 |
| 2020 Q2 | 6,226,658 | $1,045,067,619 | +$191,623,157 | $167.77 | 222 |
| 2020 Q1 | 5,157,697 | $676,659,157 | -$47,084,204 | $131.12 | 193 |
| 2019 Q4 | 5,487,562 | $816,287,431 | -$74,667,369 | $148.72 | 207 |
| 2019 Q3 | 5,992,894 | $742,538,774 | -$882,858,217 | $123.76 | 184 |
| 2019 Q2 | 12,569,930 | $1,770,181,894 | +$35,822,419 | $140.84 | 217 |
| 2019 Q1 | 12,360,195 | $1,864,503,721 | +$128,595,965 | $150.85 | 224 |
| 2018 Q4 | 11,657,169 | $1,449,690,480 | -$403,797,433 | $124.20 | 190 |
| 2018 Q3 | 14,181,041 | $2,246,741,087 | +$1,432,250,063 | $158.49 | 187 |
| 2018 Q2 | 5,133,431 | $718,724,343 | +$63,854,991 | $140.01 | 154 |
| 2018 Q1 | 4,683,224 | $622,474,212 | +$91,611,191 | $132.90 | 152 |
| 2017 Q4 | 3,984,755 | $496,314,617 | +$44,748,999 | $124.57 | 126 |
| 2017 Q3 | 3,605,567 | $446,754,001 | +$14,480,513 | $123.93 | 115 |
| 2017 Q2 | 3,492,182 | $398,275,105 | +$56,018,406 | $114.04 | 112 |
| 2017 Q1 | 3,018,492 | $316,695,674 | -$4,736,324 | $105.30 | 113 |
| 2016 Q4 | 3,095,489 | $281,588,359 | +$13,238,858 | $90.87 | 107 |
| 2016 Q3 | 2,930,364 | $291,496,084 | -$4,711,885 | $99.71 | 110 |
| 2016 Q2 | 3,076,251 | $274,668,626 | -$39,232,497 | $89.43 | 105 |
| 2016 Q1 | 3,349,153 | $294,129,961 | -$1,892,206,413 | $87.56 | 102 |
| 2015 Q4 | 21,779,226 | $2,459,415,016 | +$164,656,445 | $113.02 | 127 |
| 2015 Q3 | 20,090,644 | $2,036,625,833 | +$162,029,493 | $101.32 | 126 |
| 2015 Q2 | 18,456,703 | $2,288,765,259 | +$285,028,551 | $124.02 | 123 |
| 2015 Q1 | 16,117,838 | $1,905,196,132 | +$443,224,811 | $118.23 | 119 |
| 2014 Q4 | 12,339,312 | $1,258,885,285 | +$245,972,458 | $102.02 | 109 |
| 2014 Q3 | 9,633,125 | $883,813,866 | +$85,577,040 | $91.78 | 95 |
| 2014 Q2 | 8,789,399 | $715,910,314 | +$32,118,674 | $82.33 | 92 |
| 2014 Q1 | 8,321,792 | $638,198,251 | +$51,685,578 | $76.69 | 81 |